GKB Ophthalmics Ltd
Fundamental Score
GKB Ophthalmics Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of GKB across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Robust Profit Growth (231.15%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.
Strong Revenue Growth (15.42%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.
Consistent Growth Track Record (13.24% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.
Conservative Debt Levels (D/E: 0.28)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns and flexibility for growth investments.
Balanced Promoter Holding (51.06%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
9 factors identified
Below-Average Return on Equity (-12.66%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (-6.00%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation. Review business model and competitive positioning.
Margin Pressure Concerns (2.15%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges. Monitor for operational improvements.
Weak Interest Coverage (-0.65x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability. Monitor cash flow and debt reduction plans.
Negative Free Cash Flow (₹-3.82 Cr over 5Y)
Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.
Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.
Limited Institutional Interest (FII+DII: 1.79%)
Observation: Low institutional participation may affect liquidity and visibility.
Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
Very Low ROE
Observation: Poor capital utilization and shareholder returns.
Analysis: ROE below 5% suggests significant inefficiencies in capital deployment.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for GKB Ophthalmics Ltd
About GKB
Business Overview
GKB Ophthalmics Limited engages in manufacture and sale of unfinished ophthalmic lenses in India and internationally. The company provides semi-finished organic lenses, including single vision, bifocal, and progressive. GKB Ophthalmics Limited was incorporated in 1981 and is based in Mapusa, India.
Company Details
Key Leadership
Corporate Events
Latest News
GKB Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of GKB Ophthalmics Ltd (GKB)?
As of 09 Feb 2026, 12:22 pm IST, GKB Ophthalmics Ltd (GKB) is currently trading at ₹53.33. The stock has a market capitalization of ₹29.99 (Cr).
Is GKB share price Overvalued or Undervalued?
GKB is currently trading at a P/E ratio of 0.00x, compared to the industry average of 47.87x. Based on this relative valuation, the stock appears to be Fairly Valued against its sector peers.
What factors affect the GKB Ophthalmics Ltd share price?
Key factors influencing GKB's price include its quarterly earnings growth (Sales Growth: 15.42%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is GKB Ophthalmics Ltd a good stock for long-term investment?
GKB Ophthalmics Ltd shows a 5-year Profit Growth of N/A% and an ROE of -12.66%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.28 before investing.
How does GKB Ophthalmics Ltd compare with its industry peers?
GKB Ophthalmics Ltd competes with major peers in the Medical Equipment & Supplies. Investors should compare GKB's P/E of 0.00x and ROE of -12.66% against the industry averages to determine its competitive standing.
What is the P/E ratio of GKB and what does it mean?
GKB has a P/E ratio of N/Ax compared to the industry average of 47.87x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹N/A for every ₹1 of annual earnings.
How is GKB performing according to Bull Run's analysis?
GKB has a Bull Run fundamental score of 29.9/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does GKB belong to?
GKB operates in the Medical Equipment & Supplies industry. This classification helps understand the competitive landscape and sector-specific trends affecting GKB Ophthalmics Ltd.
What is Return on Equity (ROE) and why is it important for GKB?
GKB has an ROE of -12.66%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently GKB Ophthalmics Ltd generates profits from shareholders' equity.
How is GKB's debt-to-equity ratio and what does it indicate?
GKB has a debt-to-equity ratio of 0.28, which indicates conservative financing with low financial risk. A ratio below 1.0 generally indicates conservative financing.
What is GKB's dividend yield and is it a good dividend stock?
GKB offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has GKB grown over the past 5 years?
GKB has achieved 5-year growth rates of: Sales Growth 13.24%, Profit Growth N/A%, and EPS Growth N/A%.
What is the promoter holding in GKB and why does it matter?
Promoters hold 51.06% of GKB shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is GKB's market capitalization category?
GKB has a market capitalization of ₹30 crores, placing it in the Small-cap category.
How volatile is GKB stock?
GKB has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for GKB?
GKB has a 52-week high of ₹N/A and low of ₹N/A.
What is GKB's operating profit margin trend?
GKB has a 5-year average Operating Profit Margin (OPM) of 2.15%, indicating the company's operational efficiency.
How is GKB's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 15.42% and YoY Profit Growth of 231.15%.
What is the institutional holding pattern in GKB?
GKB has FII holding of 1.79% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.